Home
RCUS
RCUS News

Latest Arcus Biosciences Inc. (RCUS) News on May 9, 2025

MT Newswires

12 hours ago

Morgan Stanley Lowers Price Target on Arcus Biosciences to $22 From $24, Keeps Overweight Rating

Arcus Biosciences First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

2 days ago

Arcus Biosciences First Quarter 2025 Earnings: Misses Expectations

Thomson Reuters StreetEvents

2 days ago

Q1 2025 Arcus Biosciences Inc Earnings Call

Arcus Biosciences Inc (RCUS) Q1 2025 Earnings Call Highlights: Strategic Focus and Financial ...

GuruFocus.com

3 days ago

Arcus Biosciences Inc (RCUS) Q1 2025 Earnings Call Highlights: Strategic Focus and Financial ...

Argus Research

3 days ago

RCUS: What does Argus have to say about RCUS?

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates

Zacks

3 days ago

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates

Business Wire

3 days ago

Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update

Earnings To Watch: Arcus Biosciences Inc (RCUS) Reports Q1 2025 Result

GuruFocus.com

4 days ago

Earnings To Watch: Arcus Biosciences Inc (RCUS) Reports Q1 2025 Result

Business Wire

15 days ago

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire

16 days ago

Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting

Argus Research

17 days ago

RCUS: What does Argus have to say about RCUS?

Business Wire

17 days ago

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update

Argus Research

24 days ago

RCUS: Raising target price to $8.00

Business Wire

a month ago

Arcus Biosciences Announces New Employment Inducement Grants

Argus Research

a month ago

RCUS: Lowering target price to $7.00

Argus Research

a month ago

RCUS: Rating increased to a HOLD

Arcus Biosciences, Inc.'s (NYSE:RCUS) latest 8.6% decline adds to one-year losses, institutional investors may consider drastic measures

Simply Wall St.

a month ago

Arcus Biosciences, Inc.'s (NYSE:RCUS) latest 8.6% decline adds to one-year losses, institutional investors may consider drastic measures

Argus Research

a month ago

RCUS: What does Argus have to say about RCUS?

Business Wire

a month ago

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (RCUS): Among Top Insider Purchases Last Month

Insider Monkey

2 months ago

Arcus Biosciences, Inc. (RCUS): Among Top Insider Purchases Last Month

Argus Research

2 months ago

RCUS: What does Argus have to say about RCUS?

Arcus Biosciences (RCUS): Among Stocks With At Least $10 Million In Insider Spending Recently

Insider Monkey

2 months ago

Arcus Biosciences (RCUS): Among Stocks With At Least $10 Million In Insider Spending Recently

Insider Buying: Arcus Biosciences Co-Founder Bought US$201k Of Shares

Simply Wall St.

2 months ago

Insider Buying: Arcus Biosciences Co-Founder Bought US$201k Of Shares

Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.

2 months ago

Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Business Wire

2 months ago

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

MT Newswires

2 months ago

HC Wainwright Upgrades Arcus Biosciences to Buy From Neutral, Adjusts Price Target to $24 From $18

Argus Research

2 months ago

RCUS: Rating decreased to a SELL

Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates

Zacks

2 months ago

Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates

Business Wire

2 months ago

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update

Arcus Biosciences Inc (RCUS) Q4 2024: Everything You Need to Know Ahead of Earnings

GuruFocus.com

2 months ago

Arcus Biosciences Inc (RCUS) Q4 2024: Everything You Need to Know Ahead of Earnings

Business Wire

3 months ago

Arcus Biosciences Announces New Employment Inducement Grants

These Analysts Just Made A Decent Downgrade To Their Arcus Biosciences, Inc. (NYSE:RCUS) EPS Forecasts

Simply Wall St.

3 months ago

These Analysts Just Made A Decent Downgrade To Their Arcus Biosciences, Inc. (NYSE:RCUS) EPS Forecasts

Argus Research

3 months ago

RCUS: Lowering target price to $12.00

MT Newswires

3 months ago

Wedbush Cuts Arcus Biosciences' Price Target to $33 From $36, Keeps Outperform Rating

Arcus says new data demonstrated ‘best-in-class potential’ for casdatifan

TipRanks

3 months ago

Arcus says new data demonstrated ‘best-in-class potential’ for casdatifan

MT Newswires

3 months ago

Arcus Biosciences Prices $150 Million Share Offering

Business Wire

3 months ago

Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering

Business Wire

3 months ago

Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock

Business Wire

3 months ago

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

Business Wire

3 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire

3 months ago

Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium

Argus Research

3 months ago

RCUS: What does Argus have to say about RCUS?

Business Wire

4 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Argus Research

4 months ago

RCUS: What does Argus have to say about RCUS?

MT Newswires

4 months ago

Arcus Biosciences Appoints Richard Markus as Medical Chief

Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer

Business Wire

4 months ago

Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer

Argus Research

4 months ago

RCUS: Lowering target price to $15.00

Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?

Zacks

4 months ago

Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?

Business Wire

5 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Argus Research

5 months ago

RCUS: What does Argus have to say about RCUS?

Shareholders in Arcus Biosciences (NYSE:RCUS) have lost 65%, as stock drops 9.9% this past week

Simply Wall St.

5 months ago

Shareholders in Arcus Biosciences (NYSE:RCUS) have lost 65%, as stock drops 9.9% this past week

Business Wire

5 months ago

Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Argus Research

5 months ago

RCUS: Lowering target price to $17.00

Argus Research

5 months ago

RCUS: Raising target price to $18.00

Business Wire

5 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Argus Research

5 months ago

RCUS: What does Argus have to say about RCUS?

Business Wire

5 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Argus Research

5 months ago

RCUS: Raising target price to $17.00

Business Wire

6 months ago

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Argus Research

6 months ago

RCUS: Raising target price to $18.00

Business Wire

6 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Analysts Have Made A Financial Statement On Arcus Biosciences, Inc.'s (NYSE:RCUS) Third-Quarter Report

Simply Wall St.

6 months ago

Analysts Have Made A Financial Statement On Arcus Biosciences, Inc.'s (NYSE:RCUS) Third-Quarter Report

Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

GuruFocus.com

6 months ago

Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates

Zacks

6 months ago

Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates

Business Wire

6 months ago

Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update

Argus Research

6 months ago

RCUS: Lowering target price to $16.00

Business Wire

6 months ago

Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer

What To Expect From Arcus Biosciences Inc (RCUS) Q3 2024 Earnings

GuruFocus.com

6 months ago

What To Expect From Arcus Biosciences Inc (RCUS) Q3 2024 Earnings

Regeneron (REGN) Tops Q3 Earnings and Revenue Estimates

Zacks

6 months ago

Regeneron (REGN) Tops Q3 Earnings and Revenue Estimates

Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for

Zacks

6 months ago

Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for

Business Wire

6 months ago

Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting

Exelixis (EXEL) Q3 Earnings and Revenues Beat Estimates

Zacks

6 months ago

Exelixis (EXEL) Q3 Earnings and Revenues Beat Estimates

Business Wire

7 months ago

Arcus Biosciences Announces New Employment Inducement Grants

MT Newswires

7 months ago

Arcus Biosciences Reports 'Encouraging' First Data for Casdatifan in Patients With Metastatic Kidney Cancer

Business Wire

7 months ago

First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer

Business Wire

7 months ago

Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update

State Street Corp's Strategic Adjustment in Arcus Biosciences Holdings

GuruFocus.com

7 months ago

State Street Corp's Strategic Adjustment in Arcus Biosciences Holdings

Arcus Biosciences Inc (RCUS) Q2 2024 Earnings Call Highlights: Strategic Advancements Amid ...

GuruFocus.com

7 months ago

Arcus Biosciences Inc (RCUS) Q2 2024 Earnings Call Highlights: Strategic Advancements Amid ...

Business Wire

7 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc.'s (NYSE:RCUS) Intrinsic Value Is Potentially 30% Above Its Share Price

Simply Wall St.

7 months ago

Arcus Biosciences, Inc.'s (NYSE:RCUS) Intrinsic Value Is Potentially 30% Above Its Share Price

Business Wire

7 months ago

Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium

Argus Research

7 months ago

RCUS: Raising target price to $18.00

MT Newswires

7 months ago

Wells Fargo Initiates Arcus Biosciences at Overweight With $29 Price Target

MT Newswires

7 months ago

Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment

Business Wire

7 months ago

Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma

Business Wire

8 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire

8 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences obtains loan facility with Hercules Capital worth $250m

Pharmaceutical Technology

8 months ago

Arcus Biosciences obtains loan facility with Hercules Capital worth $250m

Argus Research

8 months ago

RCUS: Lowering target price to $18.00

MT Newswires

8 months ago

Arcus Biosciences Gets Up to $250 Million Term Loan Facility From Hercules Capital

Business Wire

8 months ago

Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital

Business Wire

8 months ago

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire

9 months ago

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Argus Research

9 months ago

RCUS: Raising target price to $19.00

Nuntius partners with Taiho to develop mRNA cancer therapies

Pharmaceutical Technology

9 months ago

Nuntius partners with Taiho to develop mRNA cancer therapies

Arcus Biosciences Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

9 months ago

Arcus Biosciences Second Quarter 2024 Earnings: Beats Expectations

We're Not Very Worried About Arcus Biosciences' (NYSE:RCUS) Cash Burn Rate

Simply Wall St.

9 months ago

We're Not Very Worried About Arcus Biosciences' (NYSE:RCUS) Cash Burn Rate

Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates

Zacks

9 months ago

Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates

Business Wire

9 months ago

Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates

Zacks

9 months ago

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates

Share on Social Networks: